Astellas Pharma US | Changing Tomorrow | Home

Previous Pause Next

ASTELLAS IS COMMITTED TO COMMUNITY SUPPORT

ASTELLAS IS COMMITTED TO COMMUNITY SUPPORT

We are dedicated to supporting local and global communities as part of our COVID-19 response

Astellas a Top Ten Company for Working Mothers

Astellas ranks in Top 10 of Working Mother Magazine’s Best Companies List

We are committed to creating a diverse and inclusive workplace that enables success for all employees

C3 2020

WE CAN CHANGE CANCER CARE

Astellas Oncology opens annual C3 Prize call for entries to award best innovations in cancer care beyond medicine

revised newest covid

UPDATES AND INFORMATION

Find out how we're responding to our patients, our employees and our community

1

2

3

4

News

Latest

News / Media

Oct 15, 2020

Astellas to Acquire iota Biosciences

News / Media

Sep 23, 2020

Astellas Collaborates with Two Research Centers at the University of Tokyo

News / Media

Jul 22, 2020

Astellas is Awarded Grant from the U.S. National Institutes of Health (NIH) to Fund Early Clinical Studies of ASP8062 to Investigate Potential Novel Therapeutic Approach to Address the Opioid Crisis

News / Corporate

Oct 28, 2020

Astellas Receives U.S. FDA Fast Track Designation for ASP5354, an Investigational Near-Infrared Fluorescence Imaging Agent

News / Corporate

Oct 20, 2020

U.S. FDA Grants Fast Track Designation for ASP0367/MA-0211, a Selective PPARδ Modulator being Developed for the Treatment of Primary Mitochondrial Myopathies

News / Therapeutic Area News

Oct 19, 2020

New Roxadustat Data in Anemia of Chronic Kidney Disease to be Released at ASN Kidney Week 2020 Reimagined